New Nitric Oxide-Releasing Compounds as Promising Anti-Bladder Cancer Drugs
Bladder cancer is a worldwide problem and improved therapies are urgently needed. In the search for newer strong antitumor compounds, herein, we present the study of three nitric oxide-releasing compounds and evaluate them as possible therapies for this malignancy. Bladder cancer cell lines T24 and...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , , , , , |
| Format: | article |
| Language: | English |
| Published: |
2023
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/20.500.12381/3243 https://doi.org/10.3390/biomedicines11010199 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: New Nitric Oxide-Releasing Compounds as Promising Anti-Bladder Cancer Drugs
- Jejunum-derived NF-κB reporter organoids as 3D models for the study of TNF-alpha-induced inflammation
- Generation and Characterization of Stable Redox-Reporter Mammalian Cell Lines of Biotechnological Relevance
- Tacrolimus pharmacodynamics and pharmacogenetics along the calcineurin pathway in human lymphocytes.
- Effect of tetrahydroquinoline derivatives on the intracellular Ca2+ homeostasis in breast cancer cells (MCF-7) and its relationship with apoptosis
- In situ generation, metabolism and immunomodulatory signaling actions of nitro-conjugated linoleic acid in a murine model of inflammation
- Informe final del proyecto: Generación de un sistema económico de tipificación molecular de cepas de Mycobacterium tuberculosis y su implementación en cepas aisladas en el país.